Advertisement

Topics

Drugmaker Vectura's first-half revenue up 6 percent on rising sales of inhaled products

22:41 EDT 5 Sep 2017 | Reuters

Vectura said revenue rose 6 percent in the first half of the year, driven by rising sales of its recently launched inhaled products and the continued weakness of sterling against a basket of its main trading currencies.

Original Article: Drugmaker Vectura's first-half revenue up 6 percent on rising sales of inhaled products

NEXT ARTICLE

More From BioPortfolio on "Drugmaker Vectura's first-half revenue up 6 percent on rising sales of inhaled products"

Quick Search
Advertisement
 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...